3 Results for "

intellectual disability disorders

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "intellectual disability disorders" in MCE Product Catalog:

Cat. No.: HY-W773779
CAS No.: 748145-12-2
Target:  

GSK-3

GSK3-IN-9 (Compound 0713) is a selective glycogen synthase kinase 3 (GSK3) inhibitor. GSK3-IN-9 Fragile X syndrome, attention deficit hyperactivity disorder (ADHD), childhood seizure, intellectual disability, diabetes, acute myeloid leukemia (AML), autism, and psychiatric disorder .
loading...
    loading...
Cat. No.: HY-186116
CAS No.: 1422533-70-7
Target:  

Histone Demethylase

Research Areas:  

Neurological Disease

LSD1-IN-49 is an irreversible LSD1/KDM1A inhibitor with an IC50 of 29 nM against hLSD1. LSD1-IN-49 irreversibly inhibits the enzymatic activity of LSD1 by forming an adduct with flavin adenine dinucleotide (FAD) in the binding pocket of LSD1. LSD1-IN-49 is applicable to research related to schizophrenia, autism spectrum disorder and Huntington's disease .
loading...
    loading...
Cat. No.: HY-186116A
CAS No.: 1422534-06-2
Target:  

Histone Demethylase

Research Areas:  

Neurological Disease

LSD1-IN-49 hydrochloride (Compound (±) 1) is an irreversible LSD1/KDM1A inhibitor with an IC50 of 29 nM against hLSD1. LSD1-IN-49 hydrochloride irreversibly inhibits the enzymatic activity of LSD1 by forming an adduct with flavin adenine dinucleotide (FAD) in the binding pocket of LSD1. LSD1-IN-49 hydrochloride is applicable to research related to schizophrenia, autism spectrum disorder and Huntington's disease .
loading...
    loading...